CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $271,763
- in 3 filings, $272K under 10b5-1 plans
Net −$172,432. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Boyd Peter E. Chief People Officer | Option exercise | +2,293 | $0.96 | $2K | 284,024 |
| 2026-09-09 | Boyd Peter E. Chief People Officer | Option exercise · Warrant (Right to Buy) | −2,293 | 0 | ||
| 2026-05-05 | Boyd Peter E. Chief People Officer | Shares withheld for taxes | −56,778 | $4.18 | $237K | 281,731 |
| 2026-03-10 | Boyd Peter E. Chief People Officer | Sale | −29,814 | $4.17 | $124K | 338,509 |
| 2026-03-09 | Boyd Peter E. Chief People Officer | Grant or award | +80,000 | 368,323 | ||
| 2026-03-09 | Boyd Peter E. Chief People Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +42,500 | $4.29 | $182K | 42,500 |
| 2025-12-04 | Boyd Peter E. Chief People Officer | Grant or award | +20,000 | 288,323 | ||
| 2025-10-15 | Boyd Peter E. See Remarks | Sale 10b5-1 | −10,000 | $7.00 | $70K | 268,323 |
| 2025-09-26 | Boyd Peter E. See Remarks | Sale 10b5-1 | −10,000 | $6.30 | $63K | 278,323 |
| 2025-09-05 | Boyd Peter E. See Remarks | Sale 10b5-1 | −15,000 | $5.30 | $80K | 288,323 |
| 2025-03-09 | Boyd Peter E. See Remark | Shares withheld for taxes | −7,681 | $2.65 | $20K | 303,323 |
| 2025-03-07 | Boyd Peter E. Chief People Officer | Grant or award · Performance Stock Units | +60,000 | 60,000 | ||
| 2025-03-07 | Boyd Peter E. See Remark | Grant or award | +80,000 | 317,628 | ||
| 2025-03-07 | Boyd Peter E. See Remark | Shares withheld for taxes | −6,624 | $2.65 | $18K | 311,004 |
| 2025-03-07 | Boyd Peter E. See Remark | Grant or award · Non-Qualified Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-03-09 | Boyd Peter E. See Remark | Shares withheld for taxes | −8,370 | $4.88 | $41K | 237,628 |
| 2024-03-07 | Boyd Peter E. See Remark | Grant or award | +86,250 | 245,998 | ||
| 2024-03-07 | Boyd Peter E. See Remark | Grant or award · Non-Qualified Stock Option (right to buy) | +43,125 | 43,125 | ||
| 2023-08-09 | Boyd Peter E. See Remark | Grant or award · Performance Stock Units | +50,000 | 50,000 | ||
| 2023-05-05 | Boyd Peter E. See Remark | Grant or award · Performance Stock Units | +50,000 | 50,000 |
Page 1 of 2 · 33 trades